Head-to-head · WeighScore
Eve vs Welling Health
The verdict
Welling Health takes it — 68.3/100 to 66.3/100, but only just.
Welling Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Welling Health is a clinician-led metabolic clinic offering compounded GLP-1 therapy on one transparent flat monthly rate: semaglutide from $190/month and tirzepatide from $275/month, with all doses,… Eve is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Eve | Welling Health |
|---|---|---|
| WeighScore | 66.3/100 | 68.3/100 |
| Grade | C | C |
| Scorecard rank | #189 | #149 |
| Semaglutide | $195/mo (compounded) | $190/mo (compounded) |
| Tirzepatide | $195/mo (compounded) | $275/mo (compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #189 · C
Strengths
- Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
- Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
- LegitScript Certified with a verifiable ID
- Publishes the FDA compounded-medication disclaimer
- Oral sublingual semaglutide offered alongside injectable
Where it loses points
- Full states-served list not disclosed publicly
- 503A pharmacy partner not named, and 503A vs 503B status not specified
- Named medical director / clinical leadership not disclosed
- Corporate legal entity not disclosed
- Governing law / arbitration venue not stated
Graded #149 · C
Strengths
- Transparent flat monthly rate — $190 semaglutide / $275 tirzepatide, all doses, no insurance or hidden fees
- LegitScript-certified 503A pharmacy with US-licensed clinicians in all 50 states and a named legal entity
- Streak discounts cut up to 30% — semaglutide as low as $133/month for logging meals consistently
- Free shipping, free AI macro-tracker app, and 24-hour intake review
Where it loses points
- Tirzepatide at $275/month is higher than the cheapest compounded competitors
- The streak discount requires daily in-app meal logging — miss days and you pay full rate
- The compounding pharmacy partner is described as a LegitScript-certified 503A but not named
- Only two medications — compounded semaglutide and tirzepatide; no oral or non-GLP options
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.